Cerebral complement C1q activation in chronic Toxoplasma infection

Brain, Behavior, and Immunity

Volumn 58, Issue , 2016, Pages 52-56

  Xiao, Jianchun ^a   Li, Ye ^a   Gressitt, Kristin L ^a   He, Helen ^a   Kannan, Geetha ^a,b   Schultz, Tracey L ^b   Svezhova, Nadezhda ^b   Carruthers, Vern B ^b   Pletnikov, Mikhail V ^a   Yolken, Robert H ^a   Severance, Emily G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Glia; MAG1 antibodies; Neurons; Prefrontal cortex; Psychiatry; Toxoplasmosis

Indexed keywords

COMPLEMENT COMPONENT C1Q;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRADYZOITE; BRAIN; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION; INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TOXOPLASMA GONDII; TOXOPLASMOSIS; UPREGULATION; ANIMAL; BRAIN CORTEX; CHRONIC DISEASE; CYST; IMMUNOLOGY; METABOLISM; PARASITOLOGY;

ANIMALS; CEREBRAL CORTEX; CHRONIC DISEASE; COMPLEMENT C1Q; CYSTS; FEMALE; MICE; TOXOPLASMOSIS;

EID: 84964885700     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2016.04.009     Document Type: Article

References (29)

1. Bouchut, A., Chawla, A.R., Jeffers, V., Hudmon, A., Sullivan, W.J. Jr., Proteome-wide lysine acetylation in cortical astrocytes and alterations that occur during infection with brain parasite Toxoplasma gondii. PLoS One, 10(3), 2015, e0117966.
2. Budczies, J., Klauschen, F., Sinn, B.V., Gyorffy, B., Schmitt, W.D., Darb-Esfahani, S., Denkert, C., Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PLoS One, 7(12), 2012, e51862.
3. Flegr, J., Effects of Toxoplasma on human behavior. Schizophr. Bull. 33:3 (2007), 757–760.
4. Francis, K., van Beek, J., Canova, C., Neal, J.W., Gasque, P., Innate immunity and brain inflammation: the key role of complement. Expert Rev. Mol. Med. 5:15 (2003), 1–19.
5. Fuhrman, S.A., Joiner, K.A., Complement evasion by protozoa. Exp. Parasitol. 68:4 (1989), 474–481.
6. Fuhrman, S.A., Joiner, K.A., Toxoplasma gondii: mechanism of resistance to complement-mediated killing. J. Immunol. 142:3 (1989), 940–947.
7. Halonen, S.K., Weiss, L.M., Toxoplasmosis. Handb. Clin. Neurol. 114 (2013), 125–145.
8. Haroon, F., Handel, U., Angenstein, F., Goldschmidt, J., Kreutzmann, P., Lison, H., Fischer, K.D., Scheich, H., Wetzel, W., Schluter, D., Budinger, E., Toxoplasma gondii actively inhibits neuronal function in chronically infected mice. PLoS One, 7(4), 2012, e35516.
9. Hermes, G., Ajioka, J.W., Kelly, K.A., Mui, E., Roberts, F., Kasza, K., Mayr, T., Kirisits, M.J., Wollmann, R., Ferguson, D.J., Roberts, C.W., Hwang, J.H., Trendler, T., Kennan, R.P., Suzuki, Y., Reardon, C., Hickey, W.F., Chen, L., McLeod, R., Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. J. Neuroinflammation, 5, 2008, 48.
10. Kannan, G., Pletnikov, M.V., Toxoplasma gondii and cognitive deficits in schizophrenia: an animal model perspective. Schizophr. Bull. 38 (2012), 1155–1161.
11. Markovitz, A.A., Simanek, A.M., Yolken, R.H., Galea, S., Koenen, K.C., Chen, S., Aiello, A.E., Toxoplasma gondii and anxiety disorders in a community-based sample. Brain Behav. Immun. 43 (2015), 192–197.
12. Michailidou, I., Willems, J.G., Kooi, E.J., van Eden, C., Gold, S.M., Geurts, J.J., Baas, F., Huitinga, I., Ramaglia, V., Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus. Ann. Neurol. 77:6 (2015), 1007–1026.
13. Nance, J.P., Vannella, K.M., Worth, D., David, C., Carter, D., Noor, S., Hubeau, C., Fitz, L., Lane, T.E., Wynn, T.A., Wilson, E.H., Chitinase dependent control of protozoan cyst burden in the brain. PLoS Pathog., 8(11), 2012, e1002990.
14. Prandovszky, E., Gaskell, E., Martin, H., Dubey, J.P., Webster, J.P., McConkey, G.A., The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS One, 6(9), 2011, e23866.
15. Sacks, D., Sher, A., Evasion of innate immunity by parasitic protozoa. Nat. Immunol. 3:11 (2002), 1041–1047.
16. Schreiber, R.D., Feldman, H.A., Identification of the activator system for antibody to Toxoplasma as the classical complement pathway. J. Infect. Dis. 141:3 (1980), 366–369.
17. Sekar, A., Bialas, A.R., de Rivera, H., Davis, A., Hammond, T.R., Kamitaki, N., Tooley, K., Presumey, J., Baum, M., Van Doren, V., Genovese, G., Rose, S.A., Handsaker, R.E., Daly, M.J., Carroll, M.C., Stevens, B., McCarroll, S.A., Schizophrenia risk from complex variation of complement component 4. Nature 530 (2016), 177–183.
18. Severance, E.G., Gressitt, K.L., Buka, S.L., Cannon, T.D., Yolken, R.H., Maternal complement C1q and increased odds for psychosis in adult offspring. Schizophr. Res. 159:1 (2014), 14–19.
19. Severance, E.G., Gressitt, K.L., Halling, M., Stallings, C.R., Origoni, A.E., Vaughan, C., Khushalani, S., Alaedini, A., Dupont, D., Dickerson, F.B., Yolken, R.H., Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia. Neurobiol. Dis. 48:3 (2012), 447–453.
20. Stephan, A.H., Madison, D.V., Mateos, J.M., Fraser, D.A., Lovelett, E.A., Coutellier, L., Kim, L., Tsai, H.H., Huang, E.J., Rowitch, D.H., Berns, D.S., Tenner, A.J., Shamloo, M., Barres, B.A., A dramatic increase of C1q protein in the CNS during normal aging. J. Neurosci. 33:33 (2013), 13460–13474.
21. Stevens, B., Allen, N.J., Vazquez, L.E., Howell, G.R., Christopherson, K.S., Nouri, N., Micheva, K.D., Mehalow, A.K., Huberman, A.D., Stafford, B., Sher, A., Litke, A.M., Lambris, J.D., Smith, S.J., John, S.W., Barres, B.A., The classical complement cascade mediates CNS synapse elimination. Cell 131:6 (2007), 1164–1178.
22. Tanaka, S., Nishimura, M., Ihara, F., Yamagishi, J., Suzuki, Y., Nishikawa, Y., Transcriptome analysis of mouse brain infected with Toxoplasma gondii. Infect. Immun. 81:10 (2013), 3609–3619.
23. Torrey, E.F., Bartko, J.J., Yolken, R.H., Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr. Bull. 38:3 (2012), 642–647.
24. Walport, M.J., Complement. First of two parts. N. Engl. J. Med. 344:14 (2001), 1058–1066.
25. Webster, J.P., Rats, cats, people and parasites: the impact of latent toxoplasmosis on behaviour. Microbes Infect. 3:12 (2001), 1037–1045.
26. Xiao, J., Buka, S.L., Cannon, T.D., Suzuki, Y., Viscidi, R.P., Torrey, E.F., Yolken, R.H., Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring. Microbes Infect. 11:13 (2009), 1011–1018.
27. Xiao, J., Jones-Brando, L., Talbot, C.C. Jr., Yolken, R.H., Differential effects of three canonical Toxoplasma strains on gene expression in human neuroepithelial cells. Infect. Immun. 79:3 (2011), 1363–1373.
28. Xiao, J., Li, Y., Prandovszky, E., Kannan, G., Viscidi, R.P., Pletnikov, M., Yolken, R., Behavioral abnormalities in a mouse model of chronic Toxoplasmosis are associated with MAG1 antibody levels and cyst burden. PLoS Negl Trop Dis, 2016.
29. Xiao, J., Viscidi, R.P., Kannan, G., Pletnikov, M.V., Li, Y., Severance, E.G., Yolken, R.H., Delhaes, L., The Toxoplasma MAG1 peptides induce sex-based humoral immune response in mice and distinguish active from chronic human infection. Microbes Infect. 15:1 (2013), 74–83.